BridgeMD
New treatment option for Alcohol Associated Liver Disease
Official title ADDICTOlogical Intervention in LIVEr Transplantation Recipients
ClinicalTrials.gov ID: NCT06472973
What this study is testing
- What it's testing
- Transplantation for end-stage-liver disease (ESLD) in the context of Alcohol-Associated Liver Disease (AALD) has been increasing and represents the main indication for Liver Transplantation (LT) in the world. Alcohol Use Disorder (AUD) is considered a brain chronic disease and requires a transdisciplinary approach that includes medical treatment and behavioral interventions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 years or above
- Hospitalized for LT for AALD as primary, secondary or tertiary indication
- Discharged from intensive care unit to hepatology or surgery wards
You likely can't join if
- Severe alcohol-associated hepatitis as primary indication for liver transplantation
- Impossibility of patient follow up over the next 2 years
- General criteria:
- Refusal or absence of informed consent,
- Non-affiliation to the French national health insurance,
- Persons placed under legal protection, guardianship or curatorship
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
- Bordeaux, France
- Clermont-Ferrand, France
- Dijon, France
- Lille, France
- Lyon, France
- Marseille, France
- Montpellier, France
- Nice, France
- Paris, France
- Rennes, France
- Strasbourg, France
- Toulouse, France
- Tours, France
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France; Bordeaux, France; Clermont-Ferrand, France; Dijon, France; Lille, France; Lyon, France and 8 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.